GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Intercellular Interactions Modulate Carcinogenesis Course: A Dynamic System Study

$1,344,937
Lynn Hlatky · Genesys Research Institute, Inc. · U54 · FY2013 · CA

Determining Age-Dependent Metabolic Changes in Tumors and Their Microenvironment

$1,344,763
Maria M. Mihaylova · Ohio State University · DP2 · FY2021 · CA

JPL Task Plan 82-16333, Development of the EDRN Informatics Center in Support of Biomarker Research and Validation

$1,344,065
Dan Crichton · National Cancer Institute · Y01 · FY2016 · CA

Human Melanoma - Etiology, Progression and Therapy

$1,342,967
Meenhard Herlyn · Wistar Institute · P01 · FY2009 · CA

CAR T cells targeting mesothelin and secreting bispecific antibodies targeting fibroblasts in pancreatic cancer

$1,342,869
Marcela Valderrama Maus · Massachusetts General Hospital · UG3 · FY2024 · CA

Tumor Microenvironment in Cancer Progression

$1,339,057
Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Biomarkers and Therapeutic Targets in Tumor Microenvironment and Metastasis

$1,339,057
Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Role of O-glycosylation in Animal Development

$1,337,859
Kelly G Ten Hagen · National Institute Of Dental & Craniofacial Research · ZIA · FY2012 · DE

Systems Biochemistry in Lung Cancer: Toward a Mechanistic Understanding of NSCLC

$1,337,134
Andrew N Lane · University Of Kentucky · P01 · FY2016 · CA

p53 - Regulators and Effectors

$1,335,182
Stuart A Aaronson · Icahn School Of Medicine At Mount Sinai · P01 · FY2007 · CA

p53 - Regulators and Effectors

$1,335,012
Stuart A Aaronson · Icahn School Of Medicine At Mount Sinai · P01 · FY2006 · CA

Functional Interactions between HIF-1 and ECM in Cancer

$1,333,999
Gregg L Semenza · Johns Hopkins University · U54 · FY2010 · CA

Biological mechanisms involved with PDT in the treatment of MPM

$1,333,497
Eli J Glatstein · University Of Pennsylvania · P01 · FY2017 · CA

Targeting Stoma-Tumor Co-Dependency for Glioma Therapy

$1,332,595
David H. Gutmann · Washington University · U01 · FY2011 · CA

p53 - Regulators and Effectors

$1,329,706
Stuart A Aaronson · Icahn School Of Medicine At Mount Sinai · P01 · FY2013 · CA

Multiscale Mathematical Modeling of Cancer Progression

$1,327,383
Vito Quaranta · Vanderbilt University · U54 · FY2011 · CA

Cancer Vaccines and Immunotherapy

$1,327,187
Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

Intracellular In vivo Imaging

$1,327,100
Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

Cell Migration in 3D microenvironments

$1,325,880
Clare Michal Waterman · National Heart, Lung, And Blood Institute · ZIA · FY2018 · HL

Matrix Metalloproteinases: Remodeling of the Extracellular Matrix

$1,324,461
Pamela G Robey · National Institute Of Dental & Craniofacial Research · ZIA · FY2013 · DE

The MSKCC-UW/Fred Hutch Prostate Cancer Drug Resistance and Sensitivity Center

$1,323,213
Charles L Sawyers · Sloan-Kettering Inst Can Research · U54 · FY2021 · CA

The MSKCC-UW/Fred Hutch Prostate Cancer Drug Resistance and Sensitivity Center

$1,323,213
Charles L Sawyers · Sloan-Kettering Inst Can Research · U54 · FY2019 · CA

Human Melanoma - Etiology, Progression and Therapy

$1,319,037
Meenhard Herlyn · Wistar Institute · P01 · FY2008 · CA

Preclinical Mouse Models for Studying Immune Checkpoint Inhibitor Response

$1,318,085
Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Extracellular Vesicles (EVs) and Genes in the Biology and Therapy of Gliomas

$1,316,832
Xandra Owens Breakefield · Massachusetts General Hospital · P01 · FY2018 · CA